MSL Solid Tumor |
Santiago |
Chile |
International |
Innovative Medicines |
Research & Development |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Weifang (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Weifang (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
Analista de Garantia de Qualidade Pleno |
Cambé |
Brazil |
Operations |
Innovative Medicines |
Quality |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Weifang (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Weifang (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Weifang (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
MR Intern |
Hangzhou (Zhejiang Province) |
China |
International |
Innovative Medicines |
Others |
Apr 28, 2025 |
MR Intern |
Zhengzhou (Henan Province) |
China |
International |
Universal Hierarchy Node |
Others |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Hefei (Anhui Province) |
China |
International |
Universal Hierarchy Node |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shenyang (Liaoning Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Weifang (Shandong Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Dali (Yunnan Province) |
China |
International |
Universal Hierarchy Node |
Sales |
Apr 28, 2025 |
Equipment Engineer I |
Changping County (Beijing) |
China |
Operations |
Innovative Medicines |
Technical Operations |
Apr 28, 2025 |
(高级)地区经理 |
Zhumadian (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
Equipment EngineerⅠ |
Changping County (Beijing) |
China |
Operations |
Innovative Medicines |
Technical Operations |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shenyang (Liaoning Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
Senior Statistical Programmer |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Chongqing (Chongqing Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Kaili (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Hefei (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 28, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xi an (Shaanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
Medical Science Liaison (MSL) Nephrology - Upper Midwest - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Apr 27, 2025 |
Quality Manager |
Changshu (Jiangsu Province) |
China |
Development |
Innovative Medicines |
Quality |
Apr 27, 2025 |
Specialist |
Hyderabad (Office) |
India |
Operations |
Innovative Medicines |
Quality |
Apr 27, 2025 |
Disease Area Partner (Cairo) |
Amiria |
Egypt |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
Associate Clinical Sciences Trial Leader |
Toranomon (NPKK Head Office) |
Japan |
Biomedical Research |
Pharma Research |
Research & Development |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
Medical Science Liaison (MSL) Rheumatology - IL Territory - Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
Apr 27, 2025 |
Head - Strategy & Operations, Development India |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
BD&L & Strategic Planning |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Xinxiang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Shangrao (Jiangxi Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |
(高级)医药代表 /(资深)产品专员 |
Anyang (Henan Province) |
China |
International |
Innovative Medicines |
Sales |
Apr 27, 2025 |